Clinical vaccine trial infrastructure
4 European H2020 organizations list this as part of their work.
Most active in this area
- FACULTY OF MEDICINE, UNIVERSITY OF BELGRADE
Belgrade medical faculty specializing in atrial fibrillation, cardiovascular risk stratification, and integrated care for multimorbid elderly patients in EU consortia.
“VACCELERATE positioned them as a clinical trial site within Europe's pandemic preparedness network for COVID-19 vaccine acceleration.”
RS7 projects - VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS
Lithuania's largest university hospital contributing clinical trial sites, oncology expertise, and patient data to European health research consortia.
“Participated in VACCELERATE as a clinical trial site for COVID-19 vaccine development across Europe.”
LT5 projects - FUNDACION PUBLICA GALEGA DE INVESTIGACION BIOMEDICA INIBIC
Galician biomedical research foundation specialising in bacteriophage therapy, inflammatory disease therapeutics, and clinical vaccine trial support.
“Participated as third party in VACCELERATE, the pan-European platform accelerating COVID-19 vaccine clinical trials and pandemic preparedness.”
ES4 projects - UNIWERSYTET MEDYCZNY W BIALYMSTOKU
Polish medical university with strengths in biostatistics, bioinformatics, clinical trial infrastructure, and international PhD training in biomedical sciences.
“VACCELERATE positioned them as a site in the European Corona Vaccine Trial Accelerator Platform for pandemic preparedness.”
PL3 projects